Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FX4CZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,278
Award facts
- Contract value 100% obligated
- $17,278.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,278.12 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a pharmaceutical product used in cardiology applications, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic medications supplied to federal healthcare systems.
This delivery order falls under AmerisourceBergen's prime IDC SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is registered in the System for Award Management and regularly supplies critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established relationship with DLA as a pharmaceutical prime vendor demonstrates its capability to meet federal procurement requirements across a broad spectrum of therapeutic domains and product categories.
Quick answers
Who was awarded contract SPE2DB26FX4CZ?
SPE2DB26FX4CZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FX4CZ worth?
The government has obligated $17,278 on SPE2DB26FX4CZ.
Is contract SPE2DB26FX4CZ an order under another contract?
Yes. SPE2DB26FX4CZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4CZ competed?
The extent of competition for SPE2DB26FX4CZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award